日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

水飞蓟宾与索拉非尼或吉非替尼联合治疗可增强其对肝细胞癌细胞的生长抑制作用

Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong

HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT

自体 HSCT 后接受泼尼松龙维持治疗的多发性骨髓瘤 HBsAg 阴性患者出现 HBV 再激活

Ha Ra Gu, Dong-Yeop Shin, Hong Seok Choi, Chae Ho Moon, Su Cheol Park, Hye Jin Kang